Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

CUE holding history

Cue Biopharma, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CUE overviewAll 13F holders of CUEFull Q2 2026 holdings

Shares (Q2 2026)
47,824
Value
$1.51M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CUE by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202647,824$1.51M<0.1%−1,016,866−95.5%ReducedHolders
Q1 20261,064,690$244.8K<0.1%+261,399+32.5%AddedHolders
Q4 2025803,291$245.4K<0.1%+2,523+0.3%AddedHolders
Q3 2025800,768$575.6K<0.1%+108,595+15.7%AddedHolders
Q2 2025692,173$472.4K<0.1%−1,717−0.2%ReducedHolders
Q1 2025693,890$632.3K<0.1%+62,609+9.9%AddedHolders
Q4 2024631,281$688.3K<0.1%+122,454+24.1%AddedHolders
Q3 2024508,827$385.4K<0.1%+16,371+3.3%AddedHolders
Q2 2024492,456$610.8K<0.1%−346,075−41.3%ReducedHolders
Q1 2024838,531$1.59M<0.1%+25,246+3.1%AddedHolders
Q4 2023813,285$2.15M<0.1%+50,864+6.7%AddedHolders
Q3 2023762,421$1.75M<0.1%+32,976+4.5%AddedHolders
Q2 2023729,445$2.66M<0.1%+276,677+61.1%AddedHolders
Q1 2023452,768$1.62M<0.1%+136,941+43.4%AddedHolders
Q4 2022315,827$900.0K<0.1%+17,221+5.8%AddedHolders
Q3 2022298,606$665.0K<0.1%+534+0.2%AddedHolders
Q2 2022298,072$742.0K<0.1%−250,333−45.6%ReducedHolders
Q1 2022548,405$2.68M<0.1%+27,001+5.2%AddedHolders
Q4 2021521,404$5.90M<0.1%−81,008−13.4%ReducedHolders
Q3 2021602,412$8.78M<0.1%+86,093+16.7%AddedHolders
Q2 2021516,319$6.01M<0.1%+30,270+6.2%AddedHolders
Q1 2021486,049$5.93M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.